| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of PPP1R8 mRNA | affects expression | 21346803
|
| D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in decreased expression of PPP1R8 mRNA | decreases expression | 12419474
|
| D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of PPP1R8 mRNA | affects expression | 17555576
|
| D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of PPP1R8 mRNA | increases expression | 17942748
|
| D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PPP1R8 mRNA | affects cotreatment|increases expression | 17942748
|
| D006861 |
Hydrogen Peroxide |
Hydrogen Peroxide results in decreased expression of PPP1R8 mRNA | decreases expression | 12419474
|
| C017947 |
sodium arsenite |
sodium arsenite results in increased expression of PPP1R8 protein | increases expression | 19072884
|
| D013629 |
Tamoxifen |
Tamoxifen affects the expression of PPP1R8 mRNA | affects expression | 17555576
|
| D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PPP1R8 mRNA | affects cotreatment|increases expression | 17942748
|
| D014635 |
Valproic Acid |
Valproic Acid results in decreased expression of PPP1R8 mRNA | decreases expression | 19101580
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.92 | 14745880 |
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
9.46 | 11752688 15322242 14514962 |
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
9.46 | 8875741 |
| MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
4.17 | 19490988 |
| MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.32 | 17505938 |
| MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
1.86 | 14692618 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.71 | 16835633 |
| MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
5.08 | 15276417 |
| MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
5.28 | 16712894 17306315 |
| MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.61 | 17688650 |
| MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.17 | 11748828 |
| MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.76 | 17497229 |
| MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.77 | 11256880 |
| MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.80 | 15885639 |
| MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
1.99 | 17688650 15238991 18177632 20603192 17157402 18316065 16609825 19232924 18775368 18985861 17507914 18940202 18558336 19460635 18396377 |
| MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.18 | 20046352 17594078 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.29 | 12125929 |
| MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.17 | 15340226 |
| MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
8.50 | 15746008 |
| MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
8.50 | 8888407 |
| MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
1.94 | 19059307 18629630 20390343 19487384 11161223 19189212 16273361 19221464 19200415 18351453 19289846 18815881 17242785 17893378 20859285 20544844 18997820 19011961 19244106 17440819 18821012 21138602 17261762 15565566 20135344 15668708 20065188 19115204 21152245 16202921 20005174 19084267 18984771 19142967 16818667 19189210 19288272 19410462 19066611 17049068 19155303 18855134 19103187 18425577 16873071 |
| MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.94 | 20435547 |
| MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.99 | 16835633 |
| MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.81 | 19066611 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
4.78 | 16705839 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
4.78 | 15276417 16507464 17306315 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
4.78 | 16924424 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
2.43 | 18572023 |
| MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.84 | 17572228 |
| MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.49 | 18850075 16120746 18670907 |
| MESH:D002318 |
Cardiovascular Diseases |
|
Hydrogen Peroxide |
3.67 | 16936243 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
7.28 | 6135515 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
7.28 | 19524636 20056578 |
| MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.78 | 20734317 |
| MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.38 | 16835633 |
| MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
3.05 | 17333356 17681005 11677210 16105132 17110522 16919318 15861022 |
| MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.19 | 15340226 15668235 8697196 16354765 12621046 |
| MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.27 | 14669216 17141729 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.53 | 10048152 15322242 20055451 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
2.53 | 17688650 16575769 8888407 |
| MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
4.32 | 18551238 |
| MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.67 | 19031437 |
| MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.71 | 17107852 |
| MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
3.69 | 19279558 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
6.55 | 18551238 21346803 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
6.55 | 20420201 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
6.55 | 1733752 19641884 |
| MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.93 | 11462148 |
| MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.31 | 1851702 |
| MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.61 | 12711302 11000095 |
| MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.28 | 16714409 18230668 15322242 |
| MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
9.90 | 12538720 |
| MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
9.90 | 19031437 |
| MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
3.19 | 16202921 17893378 19155303 20544844 |
| MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.25 | 10568697 9294722 |
| MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.46 | 17275665 3659116 |
| MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
4.29 | 3922381 16628512 |
| MESH:D004827 |
Epilepsy |
|
Valproic Acid |
3.04 | 20417680 18234410 |
| MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.80 | 7562514 6426943 6254150 |
| MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.60 | 7750514 |
| MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.40 | 3659116 |
| MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.19 | 11564622 |
| MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
14.57 | 15345470 |
| MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
14.57 | 14986274 19224547 |
| MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
14.57 | 19224547 14986274 |
| MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.37 | 16709447 |
| MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.76 | 11858732 |
| MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
5.26 | 16575769 |
| MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.41 | 18558336 8888407 |
| MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.87 | 14745880 |
| MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
4.52 | 19069698 |
| MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
3.25 | 20067830 |
| MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
5.02 | 16452187 |
| MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.97 | 10696789 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.44 | 11294989 10048152 |
| MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.58 | 11000095 |
| MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.20 | 15340226 16120746 12621046 |
| MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.36 | 12676792 |
| MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
5.20 | 17688650 |
| MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.42 | 8697196 18606429 15340226 16354765 16959395 |
| MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.98 | 18850075 18670907 |
| MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
4.12 | 16569931 16945680 |
| MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.72 | 12013081 |
| MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
7.16 | 17937319 |
| MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
7.16 | 15346721 12646999 |
| MESH:D007249 |
Inflammation |
|
Tamoxifen |
5.26 | 19457130 |
| MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.26 | 12200463 12878042 |
| MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.58 | 16580747 |
| MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
2.92 | 20008137 |
| MESH:D007676 |
Kidney Failure, Chronic |
|
Hydrogen Peroxide |
4.52 | 16518626 |
| MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
8.07 | 16705839 |
| MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
8.07 | 18625569 |
| MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.18 | 17596541 16294345 |
| MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.32 | 15342952 17567588 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
2.34 | 18564211 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.34 | 12878042 |
| MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
11.35 | 7678174 |
| MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
11.35 | 15276417 16712894 |
| MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
11.35 | 16684651 |
| MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
11.35 | 16984957 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
6.20 | 6135515 2876786 2876784 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
6.20 | 12151625 |
| MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.32 | 19095001 |
| MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.64 | 17228818 |
| MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
3.51 | 17306315 15276417 17077188 19931552 16712894 |
| MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
3.51 | 18625569 |
| MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.51 | 11884234 19555203 |
| MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
4.10 | 19428831 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
2.76 | 11731420 16827153 14580682 19196723 19196722 |
| MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
4.92 | 19453300 |
| MESH:D008545 |
Melanoma |
|
sodium arsenite |
3.43 | 16487513 19082730 |
| MESH:D008545 |
Melanoma |
|
Tamoxifen |
3.43 | 19393235 12393984 |
| MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
4.52 | 15990972 |
| MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.36 | 18765137 18803445 |
| MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.27 | 8888407 |
| MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.28 | 17596541 |
| MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.21 | 12213967 |
| MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
4.20 | 7678174 18551238 |
| MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
2.63 | 19393235 |
| MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.58 | 19410462 |
| MESH:D009369 |
Neoplasms |
|
sodium arsenite |
2.60 | 11559025 |
| MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.97 | 20056578 |
| MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
4.38 | 19200415 19189210 19196722 |
| MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.49 | 14600291 |
| MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
7.83 | 12854658 |
| MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
7.83 | 8888407 16359493 |
| MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
3.66 | 16049721 |
| MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
2.49 | 17306315 15276417 |
| MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.95 | 11578682 |
| MESH:D010212 |
Papilloma |
|
Hydrogen Peroxide |
4.39 | 12065085 |
| MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.62 | 12520081 |
| MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.84 | 18163543 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
10.61 | 11222880 11118676 11399792 11896295 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
10.61 | 20603192 |
| MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
3.20 | 16039940 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
3.20 | 15067354 |
| MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.65 | 15861022 16919318 |
| MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.92 | 12752131 11422049 |
| MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.12 | 18990726 |
| MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.44 | 19155313 |
| MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.09 | 19110320 15737665 |
| MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
6.47 | 18551238 |
| MESH:D012640 |
Seizures |
|
Valproic Acid |
6.47 | 11044598 15475178 14763951 16876388 3137016 17978042 1511512 11738929 |
| MESH:D012878 |
Skin Neoplasms |
|
Hydrogen Peroxide |
14.42 | 12065085 |
| MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
14.42 | 19524636 18572023 |
| MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
14.42 | 8532709 |
| MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
14.42 | 16192470 |
| MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
12.85 | 16709447 |
| MESH:D013088 |
Spermatocele |
|
Tamoxifen |
12.85 | 16709447 |
| MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
4.38 | 19457130 |
| MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
10.16 | 12854658 |
| MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
10.16 | 19490988 |
| MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.92 | 12833885 |
| MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.88 | 11994571 |
| MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.37 | 15669648 |
| MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.28 | 12697716 |
| MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.61 | 17262798 |
| MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.86 | 3119515 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
8.80 | 16049721 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
8.80 | 16452187 16712894 11723127 17306315 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
8.80 | 17572228 16712894 8653321 |
| MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.95 | 8888407 |
| MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.66 | 10091137 |
| MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
3.99 | 11813266 |
| MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.58 | 14692618 |
| MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.76 | 17056641 |
| MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.97 | 12125929 |
| MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.78 | 15869587 14671159 |
| MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.62 | 15886252 |